Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label safety. Show all posts
Showing posts with label safety. Show all posts
Friday, April 20, 2012

A prospective multicenter (phase IIIb) trialstudy of Treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis

›
A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis This...
Wednesday, March 14, 2012

Drug data reveal sneaky side effects : Nature News & Comment

›
Drug data reveal sneaky side effects : Nature    Mining of surveillance data highlights thousands of previously unknown consequences when ...
Sunday, March 11, 2012

A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites

›
A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites Objective  The reco...
Monday, January 23, 2012

abstract: The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer (phase 1)

›
Purpose: This study evaluated the clinical relevance of the dual-targeting strategy involving PI3K/AKT/mTOR and RAF/...
Sunday, May 29, 2011

Evidence Updates including professional commentaries - : Acupuncture: does it alleviate pain and are there serious risks? A review of reviews.

›
Acupuncture is commonly used for pain control, but doubts about its effectiveness and safety remain. This review was aimed at critically ...
Monday, May 23, 2011

full free access: Informa Healthcare -Review Clinical burden of venous thromboembolism

›
Conclusions: Even among high-risk groups it is not possible to identify individuals who will go on to develop VTE, and, therefore, t...
Thursday, March 10, 2011

DMBN Exclusive: Is your MRI suite safe for patients & staff?

›
Sunday, March 06, 2011

Timing of administration of bevacizumab (Avastin) chemotherapy affects wound healing after chest wall port placement - Cancer

›
Definition: dehiscence - Separation of wound edges. Abstract BACKGROUND: The authors investigated how the timing of administration of ...
Sunday, December 19, 2010

Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen - abstr

›
Monday, September 06, 2010

abstract: Monitoring long-term treatment with pegylated liposomal doxorubicin: how important is intensive cardiac follow-up?

›
"PLD is cardiac safe for long-term treatment of metastatic solid tumors. Its maximal cumulative dose remains undefined . "
Sunday, August 15, 2010

abstract: Expert Opinion on Drug Metabolism & Toxicology - Effects of herbal products on the metabolism and transport of anticancer agents

›
What the reader will gain: Potential interactions of herbal medicines with anticancer agents have become a safety concern in cancer chemoth...
Wednesday, June 23, 2010

FDA to Communicate Safety Monitoring Activities to Consumers and Health Care Professionals

›
FDA to Communicate Safety Monitoring Activities to Consumers and Health Care Professionals New website will contain safety reports on recen...

Surgical Quality Measures Not Associated with Infection Rates (U.S.)

›
Wednesday, May 05, 2010

Safety regulations stalling clinical trials - media article

›
Tuesday, May 04, 2010

Preclinical safety data reports Natural S-equol has little effect on 2 reproductive hormones

›
"About 50 percent of Asians and 20 to 30 percent of North Americans and Europeans, who in general consume less soy than Asians, have th...
Wednesday, February 10, 2010

Phase I Oncology Studies: Evidence That in the Era of Targeted Therapies Patients on Lower Doses Do Not Fare Worse — Dr Maurie Markman et al

›
abstract: "Purpose: To safely assess new drugs, cancer patients in initial cohorts of phase I oncology studies receive low drug d...
Tuesday, January 19, 2010

abstract: Safety and efficacy results of the advanced renal cell carcinoma Sorafenib expanded access program in North America

›
Note : while this is not specific to ovarian cancer knowing the side effects which patients experienced may be helpful
Sunday, December 20, 2009

Doctor and Patient - Holding Doctors Accountable for Medical Errors - NYTimes.com

›
Editorial Comment: The emphasis of this article seems to place a rather large burden on physicians which is not totally warranted. Doctor ...